Abstract
The success rates of screening programmes for Developmental Dysplasia of the Hip (DDH) vary widely. Studies on screening programmes for DDH based on a Medline search for the years 1966–1997 are reviewed. The percentage treated in most studies, especially those using ultrasound, are high and suggest substantial over-treatment. Neonatal clinical screening has the best results, but programme effectiveness increases when this is combined with secondary screening of the high-risk population. The extra costs are compensated by reduced treatment costs of late-diagnosed cases.
Original language | Undefined |
---|---|
Pages (from-to) | 49-59 |
Number of pages | 11 |
Journal | Seminars in neonatology |
Volume | 3 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1998 |
Keywords
- METIS-102910
- screening programmes
- ultrasonography
- developmental dysplasia of the hip
- infant
- newborn
- evaluation studies
- Cost-Effectiveness
- Congenital dislocation of the hip
- IR-73769